Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

He & She MD vs NP2GO

He & She MD
Graded #92

Lower grade

vs+8.700000000000003
NP2GO
Graded #37

Higher grade

The verdict

NP2GO takes it — 80.2/100 to 71.5/100.

NP2GO grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Both molecules across 40 states, but upper-mid pricing and no verification listing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNP2GO +27
54
81
Dose & formulationHe & She MD +8
88
80
Clinical oversightHe & She MD +5
84
79
Labs & monitoringNP2GO +16
62
78
FulfillmentHe & She MD +10
92
82
Contract termsNP2GO +41
41
82
He & She MD · left barNP2GO · right bar

The numbers

MetricHe & She MDNP2GO
WeighScore71.5/10080.2/100
GradeCB−
Scorecard rank#92#37
Semaglutide$139/mo (starting dose, promotional rate, compounded)$150/mo
Tirzepatide$199/mo (starting dose, compounded)$250/mo
CoverageAll 50 states40 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
He & She MD

Graded #92 · C

Strengths

  • Transparent intro pricing: injectable GLP-1 from $139/month, oral from $199, microdose from $99
  • Compounded semaglutide and tirzepatide (injectable or oral) plus brand access to Ozempic, Wegovy, Zepbound
  • Only charged if medication is prescribed; no hidden fees
  • Free expedited shipping and unlimited board-certified clinician access
  • GLP-1 coaching, nutrition guidance, and in-app progress tracking

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products (per the site FDA disclaimer)
  • Does not ship to Louisiana or to PO boxes
  • Introductory pricing rises after the 6-month (or 3-month microdose) plan
  • Cash-pay model — insurance billing not indicated
NP2GO

Graded #37 · B−

Strengths

  • Both molecules
  • 40-state footprint
  • Transparent listed pricing

Where it loses points

  • Not LegitScript-verified
  • Upper-mid pricing ($150/$250)
  • Not all 50 states

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard